.jpg)
.png)
NLA News
Alan Brown, MD, FNLA President It has been an honor to serve as the President of the National Lipid Association (NLA) for the 2018-19 organizational year, and I look forward to the rest of my term through the 2019 Scientific Sessions. I hope everyone had a wonderful holiday and want to... more
Further analysis from the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health (AIM-HIGH) trial was presented on November 15, 2011, at the American Heart Association (AHA) 2011 Scientific Sessions. The investigators echoed previous statements... more
The National Lipid Association is excited to announce a month-long extravaganza of virtual education, LipidPALOOZA, launching this September to celebrate National Cholesterol Education Month. There will be a variety of activities spread throughout the entire month and best of all, they will be... more
Experts in the field of clinical lipidology elected as officers of medical society focused on treating cardiometabolic disorders (JACKSONVILLE, FLA.)—The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election... more
The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on Lipid Disorders in Children and Adolescents: Screening. NLA leadership disagrees with this release and communicated twice to USPSTF about the implications of this statement. The... more
During February—which is American Heart Month—the National Lipid Association (NLA) would like to recognize the important work underway by Million Hearts. This national initiative was launched by the Department of Health and Human Services in 2012, with the exciting goal of preventing 1 million... more
The 2016 American College of Cardiology (ACC) Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk By Carl Orringer, MD, FNLA Following “LDL Think Tank” meeting convened by ACC in October 2015, a meeting attended by... more
December 7, 2017 — The National Lipid Association (NLA) was recently awarded accredited provider status for Joint Accreditation in Inter-professional Continuing Education. Joint Accreditation offers organizations such as the NLA the opportunity to be simultaneously accredited to provide medical,... more
Sanofi and Regeneron announced on Monday, Feb. 11 alirocumab will be made available at a reduced list price to help lower patient out-of-pocket costs and improve access. This follows an earlier announcement in March 2018, when Sanofi and Regeneron committed to lower the U.S. net price for payers... more
An International Masters in Lipidology course debuted in Sydney, Australia in late October 2010. The international faculty included: Dr. Gerald Watts Dr. John Chapman, President of the European Atherosclerosis Society Dr. Richard O'Brien Dr. David Sullivan, Past President of the... more